Review article: Can post-operative recurrence in Crohn's disease be prevented?

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue SUPPL. 3, 2006, Pages 22-28

  Lemann M ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN A; INFLIXIMAB; INTERLEUKIN 10; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; MYCOPHENOLIC ACID; ORNIDAZOLE; PLACEBO; PROBIOTIC AGENT; TACROLIMUS;

CLINICAL TRIAL; CROHN DISEASE; HUMAN; META ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; HUMANS; POSTOPERATIVE COMPLICATIONS; PROBIOTICS; RECURRENCE; RISK FACTORS;

EID: 33748288102     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03055.x     Document Type: Review

References (34)

1. Williams JG, Wong WD, Rothenberger DA, Goldberg SM. Recurrence of Crohn's disease after resection. Br J Surg 1991; 78: 10.
2. Yamamoto T, Keighley MR. Smoking and disease recurrence after operation for Crohn's disease. Br J Surg 2000; 87: 398-404.
3. Cottone M, Orlando A, Viscido A, Calabrese E, Camma C, Casa A. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease. Aliment Pharmacol Ther 2003; 17 (Suppl. 2): 38-42.
4. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterol 1990; 98: 1123-8.
5. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterol 1994; 106: 643-8.
6. Travis S, Stange EF, Lemann M, et al. European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55 (Suppl. 1): i16-35.
7. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterol 1990; 99: 956-63.
8. Rutgeerts PJ, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence of: a randomized double blind placebo controlled trial. Gastroenterol 2005; 128: 856-61.
9. Viscido A, Corrao G, Taddei G, Caprilli R. Crohn's disease activity index is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Ital J Gastroenterol Hepatol 1999; 31: 274-9.
10. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterol 1995; 109: 404-13.
11. Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterol 1995; 108: 345-9.
12. Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Eur J Gastroenterol Hepatol 1996; 8: 229-33.
13. Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994; 8: 35-43.
14. Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterol 1997; 112: 1069-77.
15. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterol 2000; 118: 264-73.
16. Campieri M, Rizzello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of postoperative recurrence of Crohn's disease: a randomized study vs mesalamine. Gastroenterol 2000; 118: 4179.
17. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Post-operative maintenance of Crohn's disease remission with mercaptopurine, and MP to 6-MP, mesalamine or placebo: a 2 year trial. Gastroenterol 2004; 127: 723-9.
18. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterol 2004; 127: 730-7.
19. Cammà C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterol 1997; 113: 1465-73.
20. Cottone M, Cammà C. Mesalamine and relapse prevention in Crohn's disease. Gastroenterol 2000; 118: 597.
21. Cammà C, Viscido A, Latella G, Caprilli R, Cottone M. Mesalamine in the prevention of clinical and endoscopic postoperative recurrence of Crohn's disease: a meta-analysis. Dig Liver Dis 2002; 34: A86.
22. Caprilli R, Cottone M, Tonelli F, et al. Two mesalazine regimens in the prevention of the postoperative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003; 17: 517-23.
23. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterol 1995; 108: 1617-21.
24. Korelitz B, Hanauer S, Rutgeerts P, Present D, Peppercorn M. Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: a 2 year multicenter trial. Gastroenterol 1998; 114: A1011.
25. Sandborn WJ, Feagan BG. The efficacy of azathioprine and mercaptopurine, and MP to 6-MP for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain. Gastroenterol 2004; 127: 990-3.
26. Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 2003; 4: CD000301.
27. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterol 1999; 116: 294-300.
28. Ewe K, Bottger T, Buhr HJ, Ecker KW, Otto HF. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur J Gastroenterol Hepatol 1999; 11: 277-82.
29. Papi C, Luchetti R, Gili L, Montanti S, Koch M, Capurso L. Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther 2000; 14: 1419-28.
30. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002; 51: 405-9.
31. Marteau P, Lémann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebo-controlled GETAID trial. Gut 2006; 55: 842-7.
32. Van Gossum A, Dewit O, Geboes K, et al. A randomized placebo-controlled clinical trial of probiotics ( L. johnsonii La1) on early endoscopic recurrence of Crohn's disease (CD) after ileocaecal resection. Gastroenterol 2005; 128: A17.
33. Colombel JF, Rutgeerts P, Malchow H, et al. (Tenovil) in the prevention of post-operative recurrence of Crohn's disease. Gut 10 2001; 42-6.
34. Belluzzi A, Campieri M, Belloli C, et al. A new enteric-coated preparation of Ω-3 fatty acids for preventing post-surgical recurrence in Crohn's disease. Gastroenterol 1997; 112: A930.